SCHEMBL23090409

SCHEMBL23090409

COc1cc2c(cc1C(=O)Nc1ccc(-c3cc[nH]n3)cc1)CCCCC2

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 3/20 0.63
▸ FLT3 P36888 2/20 0.46
▸ MELK Q14680 2/20 0.46
▸ CAMK2G Q13555 1/20 0.46
▸ CAMK2D Q13557 1/20 0.46
▸ MYLK Q15746 1/20 0.46
▸ MKNK2 Q9HBH9 1/20 0.46
▸ MEN1 O00255 5/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ LMNA P02545 3/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ MAPT P10636 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ POLB P06746 3/20 0.41
▸ AHR P35869 1/20 0.41
▸ NR1H4 Q96RI1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23090371 0.82 DHODH (0.71) DHODHMEN1KMT2ARAB9ANPC1
SCHEMBL23090382 0.78 DHODH (1.00) DHODHMEN1KMT2ARAB9ANPC1
SCHEMBL23090367 0.77 DHODH (1.00) DHODHMEN1KMT2ARAB9ANPC1
SCHEMBL23090385 0.75 DHODH (0.70) DHODHMEN1KMT2ARAB9ANPC1
SCHEMBL23090379 0.74 DHODH (0.78) DHODHMEN1KMT2ARAB9ANPC1
SCHEMBL23090416 0.73 DHODH (1.00) DHODHMEN1KMT2ARAB9ANPC1
SCHEMBL23090415 0.72 MEN1 (0.62) DHODHMEN1KMT2ARAB9ANPC1
SCHEMBL23651305 0.70 DHODH (0.77) DHODHMEN1KMT2ARAB9ANPC1
SCHEMBL23651289 0.69 DHODH (0.59) DHODHMEN1KMT2ARAB9ANPC1
SCHEMBL23090366 0.69 DHODH (0.57) DHODHMEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885FLT3 1447/4885MELK 204/4885
US-11066357-B2 Benzoannulene derivatives as antiviral agents ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885FLT3 1447/4885MELK 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback